flurbiprofen has been researched along with Bright Disease in 2 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joy, MS | 1 |
| Frye, RF | 1 |
| Nolin, TD | 1 |
| Roberts, BV | 1 |
| La, MK | 1 |
| Wang, J | 1 |
| Brouwer, KL | 1 |
| Dooley, MA | 1 |
| Falk, RJ | 1 |
| Thebault, JJ | 1 |
| Lagrue, G | 1 |
| Blatrix, CE | 1 |
| Cheynier, L | 1 |
| Cluzan, R | 1 |
1 trial available for flurbiprofen and Bright Disease
| Article | Year |
|---|---|
In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases.
Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Breath Tests; Case-Control Studies; Cytochrome | 2014 |
1 other study available for flurbiprofen and Bright Disease
| Article | Year |
|---|---|
Clinical pharmacology of flurbiprofen: a novel inhibitor of platelet aggregation.
Topics: Adenosine Diphosphate; Chronic Disease; Collagen; Dose-Response Relationship, Drug; Flurbiprofen; Gl | 1977 |